Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Deficiency of CCN5/WISP-2-Driven Program in breast cancer Promotes Cancer Epithelial cells to mesenchymal stem cells and Breast Cancer growth.

Das A, Dhar K, Maity G, Sarkar S, Ghosh A, Haque I, Dhar G, Banerjee S, Banerjee SK.

Sci Rep. 2017 Apr 27;7(1):1220. doi: 10.1038/s41598-017-00916-z.

2.

CHL1 hypermethylation as a potential biomarker of poor prognosis in breast cancer.

Martín-Sánchez E, Mendaza S, Ulazia-Garmendia A, Monreal-Santesteban I, Blanco-Luquin I, Córdoba A, Vicente-García F, Pérez-Janices N, Escors D, Megías D, López-Serra P, Esteller M, Illarramendi JJ, Guerrero-Setas D.

Oncotarget. 2017 Feb 28;8(9):15789-15801. doi: 10.18632/oncotarget.15004.

3.

Parity, hormones and breast cancer subtypes - results from a large nested case-control study in a national screening program.

Ellingjord-Dale M, Vos L, Tretli S, Hofvind S, Dos-Santos-Silva I, Ursin G.

Breast Cancer Res. 2017 Jan 23;19(1):10. doi: 10.1186/s13058-016-0798-x.

4.

Reproductive factors and the risk of triple-negative breast cancer in white women and African-American women: a pooled analysis.

Ma H, Ursin G, Xu X, Lee E, Togawa K, Duan L, Lu Y, Malone KE, Marchbanks PA, McDonald JA, Simon MS, Folger SG, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L.

Breast Cancer Res. 2017 Jan 13;19(1):6. doi: 10.1186/s13058-016-0799-9.

5.
6.

Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.

Zhang L, Chen Z, Xue D, Zhang Q, Liu X, Luh F, Hong L, Zhang H, Pan F, Liu Y, Chu P, Zheng S, Lou G, Yen Y.

Oncol Rep. 2016 Nov;36(5):2489-2500. doi: 10.3892/or.2016.5112. Epub 2016 Sep 20.

7.

Recreational physical activity and risk of triple negative breast cancer in the California Teachers Study.

Ma H, Xu X, Clague J, Lu Y, Togawa K, Wang SS, Clarke CA, Lee E, Park HL, Sullivan-Halley J, Neuhausen SL, Bernstein L.

Breast Cancer Res. 2016 Jun 17;18(1):62. doi: 10.1186/s13058-016-0723-3.

8.

Selective Vulnerability of Cancer Cells by Inhibition of Ca(2+) Transfer from Endoplasmic Reticulum to Mitochondria.

Cárdenas C, Müller M, McNeal A, Lovy A, Jaňa F, Bustos G, Urra F, Smith N, Molgó J, Diehl JA, Ridky TW, Foskett JK.

Cell Rep. 2016 Mar 15;14(10):2313-24. doi: 10.1016/j.celrep.2016.02.030. Epub 2016 Mar 3. Erratum in: Cell Rep. 2016 Apr 5;15(1):219-20.

9.

Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies.

Sisti JS, Collins LC, Beck AH, Tamimi RM, Rosner BA, Eliassen AH.

Int J Cancer. 2016 May 15;138(10):2346-56. doi: 10.1002/ijc.29968. Epub 2016 Feb 8.

10.

CD24 Overexpression Is Associated with Poor Prognosis in Luminal A and Triple-Negative Breast Cancer.

Kwon MJ, Han J, Seo JH, Song K, Jeong HM, Choi JS, Kim YJ, Lee SH, Choi YL, Shin YK.

PLoS One. 2015 Oct 7;10(10):e0139112. doi: 10.1371/journal.pone.0139112. eCollection 2015.

12.

Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study.

de Gonzalo-Calvo D, López-Vilaró L, Nasarre L, Perez-Olabarria M, Vázquez T, Escuin D, Badimon L, Barnadas A, Lerma E, Llorente-Cortés V.

BMC Cancer. 2015 Jun 9;15:460. doi: 10.1186/s12885-015-1469-5.

13.

Transcriptional implications of intragenic DNA methylation in the oestrogen receptor alpha gene in breast cancer cells and tissues.

Shenker NS, Flower KJ, Wilhelm-Benartzi CS, Dai W, Bell E, Gore E, El Bahrawy M, Weaver G, Brown R, Flanagan JM.

BMC Cancer. 2015 May 1;15:337. doi: 10.1186/s12885-015-1335-5.

14.

Reduced risk of breast cancer associated with recreational physical activity varies by HER2 status.

Ma H, Xu X, Ursin G, Simon MS, Marchbanks PA, Malone KE, Lu Y, McDonald JA, Folger SG, Weiss LK, Sullivan-Halley J, Deapen DM, Press MF, Bernstein L.

Cancer Med. 2015 Jul;4(7):1122-35. doi: 10.1002/cam4.465. Epub 2015 Apr 27.

15.
16.

SLUG: Critical regulator of epithelial cell identity in breast development and cancer.

Phillips S, Kuperwasser C.

Cell Adh Migr. 2014;8(6):578-87. doi: 10.4161/19336918.2014.972740. Review.

17.

Mutational profiles in triple-negative breast cancer defined by ultradeep multigene sequencing show high rates of PI3K pathway alterations and clinically relevant entity subgroup specific differences.

Kriegsmann M, Endris V, Wolf T, Pfarr N, Stenzinger A, Loibl S, Denkert C, Schneeweiss A, Budczies J, Sinn P, Weichert W.

Oncotarget. 2014 Oct 30;5(20):9952-65.

18.

Prognostic and therapeutic significance of ribonucleotide reductase small subunit M2 in estrogen-negative breast cancers.

Zhang H, Liu X, Warden CD, Huang Y, Loera S, Xue L, Zhang S, Chu P, Zheng S, Yen Y.

BMC Cancer. 2014 Sep 11;14:664. doi: 10.1186/1471-2407-14-664.

19.

How many etiological subtypes of breast cancer: two, three, four, or more?

Anderson WF, Rosenberg PS, Prat A, Perou CM, Sherman ME.

J Natl Cancer Inst. 2014 Aug 12;106(8). pii: dju165. doi: 10.1093/jnci/dju165. Print 2014 Aug. Review.

20.

Differential peripheral blood gene expression profile based on Her2 expression on primary tumors of breast cancer patients.

Tudoran O, Virtic O, Balacescu L, Pop L, Dragla F, Eniu A, Fetica B, Balacescu O, Berindan-Neagoe I.

PLoS One. 2014 Jul 28;9(7):e102764. doi: 10.1371/journal.pone.0102764. eCollection 2014. Erratum in: PLoS One. 2014;9(10):e110962.

Supplemental Content

Support Center